Adult stem cells and heart regeneration

References

• Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation113(6), E85–E151 (2006).
   PubMed Web of Science ®Google Scholar
• Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell100(1), 157–168 (2000).
   PubMed Web of Science ®Google Scholar
• Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev.85(4), 1373–1416 (2005).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114(6), 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Torella D, Sheikh F et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl Acad. Sci. USA102(24), 8692–8697 (2005).
   PubMed Web of Science ®Google Scholar
• Torella D, Ellison GM, Mendez-Ferrer S, Ibanez B, Nadal-Ginard B. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S8–S13 (2006).
   PubMedGoogle Scholar
• Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA100(21), 12313–12318 (2003).
   PubMed Web of Science ®Google Scholar
• Bradfute SB, Graubert TA, Goodell MA. Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp. Hematol.33(7), 836–843 (2005).
   PubMed Web of Science ®Google Scholar
• Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett.530(1–3), 239–243 (2002).
   PubMed Web of Science ®Google Scholar
• Asakura A, Rudnicki MA. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol.30(11), 1339–1345 (2002).
   PubMed Web of Science ®Google Scholar
• Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells24(1), 3–12 (2006).
   PubMed Web of Science ®Google Scholar
• Martin CM, Meeson AP, Robertson SM et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol.265(1), 262–275 (2004).
   PubMed Web of Science ®Google Scholar
• Mouquet F, Pfister O, Jain M et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ. Res.97(11), 1090–1092 (2005).
   PubMed Web of Science ®Google Scholar
• Pfister O, Mouquet F, Jain M et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res.97(1), 52–61 (2005).
   PubMed Web of Science ®Google Scholar
• Tomita Y, Matsumura K, Wakamatsu Y et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J. Cell Biol.170(7), 1135–1146 (2005).
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res.95(9), 911–921 (2004).
   PubMed Web of Science ®Google Scholar
• Laugwitz KL, Moretti A, Lam J et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature433(7026), 647–653 (2005).
   PubMed Web of Science ®Google Scholar
• Moretti A, Caron L, Nakano A et al. Multipotent embryonic Isl1(+) progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell127(6), 1151–1165 (2006).
   PubMed Web of Science ®Google Scholar
• Mauro A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol.9, 493–495 (1961).
   PubMed Web of Science ®Google Scholar
• Siminiak T, Kalmucki P, Kurpisz M. Autologous skeletal myoblasts for myocardial regeneration. J. Interv. Cardiol.17(6), 357–365 (2004).
   PubMedGoogle Scholar
• Chachques JC, Acar C, Herreros J et al. Cellular cardiomyoplasty: clinical application. Ann. Thorac. Surg.77(3), 1121–1130 (2004).
   PubMed Web of Science ®Google Scholar
• Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J. Mol. Cell Cardiol.34(3), 251–253 (2002).
   PubMed Web of Science ®Google Scholar
• Rubart M, Soonpaa MH, Nakajima H, Field LJ. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J. Clin. Invest.114(6), 775–783 (2004).
   PubMed Web of Science ®Google Scholar
• Jain M, DerSimonian H, Brenner DA et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation103(14), 1920–1927 (2001).
   PubMed Web of Science ®Google Scholar
• Menasche P. Skeletal myoblast transplantation for cardiac repair. Expert Rev. Cardiovasc. Ther.2(1), 21–28 (2004).
   PubMedGoogle Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410(6829), 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest.107(11), 1395–1402 (2001).
   PubMed Web of Science ®Google Scholar
• Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med.10(5), 494–501 (2004).
   PubMed Web of Science ®Google Scholar
• Lapidos KA, Chen YE, Earley JU et al. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J. Clin. Invest.114(11), 1577–1585 (2004).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275(5302), 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med.7(4), 430–436 (2001).
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Kawamoto A, Ishikawa M et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation113(10), 1311–1325 (2006).
   PubMed Web of Science ®Google Scholar
• Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest.103(5), 697–705 (1999).
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science284(5411), 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309), 71–74 (1997).
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr. Opin. Immunol.18(5), 586–591 (2006).
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng.7(2), 211–228 (2001).
   PubMedGoogle Scholar
• Planat-Benard V, Menard C, Andre M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res.94(2), 223–229 (2004).
   PubMed Web of Science ®Google Scholar
• Rehman J, Considine RV, Bovenkerk JE et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J. Am. Coll. Cardiol.41(8), 1408–1413 (2003).
   PubMed Web of Science ®Google Scholar
• Rehman J, Traktuev D, Li J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation109(10), 1292–1298 (2004).
   PubMed Web of Science ®Google Scholar
• Guan K, Nayernia K, Maier LS et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature440(7088), 1199–1203 (2006).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation107(3), 461–468 (2003).
   PubMed Web of Science ®Google Scholar
• Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med.9(9), 1195–1201 (2003).
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl Acad. Sci. USA98(18), 10344–10349 (2001).
   PubMed Web of Science ®Google Scholar
• Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol.34(2), 241–249 (2002).
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med.11(4), 367–368 (2005).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med.5(4), 434–438 (1999).
   PubMed Web of Science ®Google Scholar
• Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res.98(11), 1414–1421 (2006).
   PubMed Web of Science ®Google Scholar
• Misao Y, Takemura G, Arai M et al. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation. Cardiovasc. Res.69(2), 476–490 (2006).
   PubMed Web of Science ®Google Scholar
• Tang YL, Zhao Q, Qin X et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg.80(1), 229–236 (2005).
   PubMed Web of Science ®Google Scholar
• Kinnaird T, Stabile E, Burnett MS, Epstein SE. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ. Res.95(4), 354–363 (2004).
   PubMed Web of Science ®Google Scholar
• Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res.94(5), 678–685 (2004).
   PubMed Web of Science ®Google Scholar
• Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation109(12), 1543–1549 (2004).
   PubMed Web of Science ®Google Scholar
• Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest.116(7), 1865–1877 (2006).
   PubMed Web of Science ®Google Scholar
• Rangappa S, Entwistle JW, Wechsler AS, Kresh JY. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J. Thorac. Cardiovasc. Surg.126(1), 124–132 (2003).
   PubMed Web of Science ®Google Scholar
• Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T. Catheter-based delivery of cells to the heart. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S57–S64 (2006).
   PubMedGoogle Scholar
• Perin EC, Lopez J. Methods of stem cell delivery in cardiac diseases. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S110–S113 (2006).
   PubMedGoogle Scholar
• Aicher A, Brenner W, Zuhayra M et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation107(16), 2134–2139 (2003).
   PubMed Web of Science ®Google Scholar
• Kraitchman DL, Tatsumi M, Gilson WD et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation112(10), 1451–1461 (2005).
   PubMed Web of Science ®Google Scholar
• Kurpisz M, Czepczynski R, Grygielska B et al. Bone marrow stem cell imaging after intracoronary administration. Int. J. Cardiol. DOI:10.1016/j.ijcard. 2006.08.062 (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• Siminiak T, Fiszer D, Jerzykowska O et al. Percutaneous trans-coronary–venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur. Heart J.26(12), 1188–1195 (2005).
   PubMed Web of Science ®Google Scholar
• Menasche P, Hagege AA, Vilquin JT et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol.41(7), 1078–1083 (2003).
   PubMed Web of Science ®Google Scholar
• Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet363(9411), 783–784 (2004).
   PubMed Web of Science ®Google Scholar
• Han CI, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res.38(2), 113–119 (2001).
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation106(15), 1913–1918 (2002).
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation106(24), 3009–3017 (2002).
   PubMed Web of Science ®Google Scholar
• Britten MB, Abolmaali ND, Assmus B et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI), mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation108(18), 2212–2218 (2003).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Britten MB et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol.44(8), 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1210–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet364(9429), 141–148 (2004).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367(9505), 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat. Clin. Pract. Cardiovasc. Med.3(Suppl. 1), S23–S28 (2006).
   PubMedGoogle Scholar
• Schachinger V, Erbs S, Elsassar A. et al. Intracoronary infusion of bone-marrow-derived progenitor cells is associated with improved clinical outcome in patients with acute myocardial infarction: 12 months follow up of the REPAR-AMI trial. Circulation114, II-787 (2006).
   Google Scholar
• Assmus B, Urbich C, Aicher A et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res.92(9), 1049–1055 (2003).
   PubMed Web of Science ®Google Scholar
• Rupp S, Badorff C, Koyanagi M et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res. Cardiol.99(1), 61–68 (2004).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Rigolin GM, Fucili A et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation110(10), 1209–1212 (2004).
   PubMed Web of Science ®Google Scholar
• Suzuki K, Brand NJ, Allen S et al. Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. Surg.122(4), 759–766 (2001).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl Acad. Sci. USA100(18), 10440–10445 (2003).
   PubMed Web of Science ®Google Scholar
• Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA102(25), 8966–8971 (2005).
   PubMed Web of Science ®Google Scholar
• Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem.279(12), 11384–11391 (2004).
   PubMed Web of Science ®Google Scholar